Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 55

Sort by

Sort Order Select

Journal Articles

The academic center effect: Better outcomes for patients with DLBCL

Carolina Velez-Mejia, Laura Reyes-Uribe, Eleftheria Atalla, Ysaith Orellana Ascencio, Qianqian Liu, Joel Michalek, Leyla Bojanini, Supreet Kaur, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 6314.

https://doi.org/10.1182/blood-2025-6314

Published: 2025

Journal Articles

Patients with burkitt's lymphoma have a better survival probability if treated in an academic cancer program

Carolina Velez-Mejia, Ysaith Orellana Ascencio, Laura Reyes-Uribe, Eleftheria Atalla, Joel Michalek, Qianqian Liu, Supreet Kaur, Leyla Bojanini, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 6311.

https://doi.org/10.1182/blood-2025-6311

Published: 2025

Journal Articles

A national lens on follicular lymphoma: Academic care linked to improved survival in 158,000 patients

Daniel Rosas, Leyla Bojanini, Supreet Kaur, Erin Kaser, Victor Mendiola, Vanessa Velazquez, Gabriel Giraldo, Qianqian Liu, Joel Michalek, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 2628.

https://doi.org/10.1182/blood-2025-2628

Published: 2025

Journal Articles

Facility type and survival outcomes in extranodal NK/T-cell lymphoma, nasal type: A national cancer database analysis

Gabriel Giraldo Ospino, Leyla Bojanini, Erin Kaser, Victor Mendiola, Vanessa Velazquez, Daniel Rosas, Qianqian Liu, Joel Michalek, Supreet Kaur, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 8022.

https://doi.org/10.1182/blood-2025-8022

Published: 2025

Journal Articles

Same outcomes, different odds: Socioeconomic disparities in PMBCL care across u.S. cancer centers

Laura Reyes-Uribe, Carolina Velez-Mejia, Ysaith Orellana Ascencio, Eleftheria Atalla, Qianqian Liu, Joel Michalek, Leyla Bojanini, Supreet Kaur, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 5445.

https://doi.org/10.1182/blood-2025-5445

Published: 2025

Journal Articles

Academic advantage without survival benefit? a national cancer database analysis of primary effusion lymphoma

Laura Reyes-Uribe, Carolina Velez-Mejia, Ysaith Orellana Ascencio, Eleftheria Atalla, Qianqian Liu, Joel Michalek, Leyla Bojanini, Supreet Kaur, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 5444.

https://doi.org/10.1182/blood-2025-5444

Published: 2025

Journal Articles

Real-world outcomes in T-cell/histiocyte-rich large B-cell lymphoma: Insights from the largest u.S. cohort to date

Laura Reyes-Uribe, Carolina Velez-Mejia, Ysaith Orellana Ascencio, Eleftheria Atalla, Qianqian Liu, Joel Michalek, Leyla Bojanini, Supreet Kaur, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 3662.

https://doi.org/10.1182/blood-2025-3662

Published: 2025

Journal Articles

A tale of two settings: Survival disparities in CLL/SLL between academic and community cancer programs in the u.S. national cancer database

William Ciurylo, Supreet Kaur, Eleftheria Atalla, Aymen Baig, Oscar Hinojosa Castro, Erin Christine Kaser, Victor Mendiola, Ysaith Orellana Ascencio, Laura Reyes-Uribe, Daniel Rosas, Ahmed Sandu, Esteban Toro Velez, Vanessa Velazquez, Carolina Velez-Mejia, Nikki Verma, Joel Michalek, Qianqian Liu, Leyla Bojanini Molina, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 4403.

https://doi.org/10.1182/blood-2025-4403

Published: 2025

Journal Articles

Unequal outcomes: The role of institutional setting in the management of primary CNS lymphoma

Ysaith Orellana Ascencio, Supreet Kaur, Leyla Bojanini, Laura Reyes-Uribe, Carolina Velez-Mejia, Eleftheria Atalla, Joel Michalek, Qianqian Liu, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 4493.

https://doi.org/10.1182/blood-2025-4493

Published: 2025

Journal Articles

Academic cancer programs deliver improved long-term survival in nodular lymphocyte predominant Hodgkin lymphoma: Insights from 7,000+ United States patients

Nikki Verma, Supreet Kaur, Aymen Baig, William Ciurylo, Esteban Toro Velez, Joel Michalek, Qianqian Liu, Leyla Bojanini Molina, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 2733.

https://doi.org/10.1182/blood-2025-2733

Published: 2025

Journal Articles

Outcomes of primary cutaneous anaplastic large cell lymphoma across u.S. cancer care settings: A national cancer database analysis.

Victor Mendiola, Leyla Bojanini, Erin Kaser, Daniel Rosas, Vanessa Velazquez, Gabriel Giraldo, Qianqian Liu, Joel Michalek, Supreet Kaur, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 5419.

https://doi.org/10.1182/blood-2025-5419

Published: 2025

Journal Articles

Comparative outcomes of 14,650 patients with mycosis fungoides/Sézary syndrome from academic and community cancer programs

Erin Kaser, Leyla Bojanini, Vanessa Velazquez, Gabriel Giraldo, Victor Mendiola, Daniel Rosas, Supreet Kaur, Qianqian Liu, Joel Michalek, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 5416.

https://doi.org/10.1182/blood-2025-5416

Published: 2025

Journal Articles

Clinical disparities in enteropathy-associated T-cell lymphoma: A national cancer database study of 736 patients treated at academic and community cancer centers

Oscar Hinojosa, Supreet Kaur, Leyla Bojanini, Joel Michalek, Qianqian Liu, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 5413.

https://doi.org/10.1182/blood-2025-5413

Published: 2025

Journal Articles

Curable but not equal: Survival disparities in classic Hodgkin lymphoma by treatment facility type in the United States

Aymen Baig, Supreet Kaur, Nikki Verma, William Ciurylo, Esteban Toro Velez, Leyla Bojanini, Qianqian Liu, Joel Michalek, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 5396.

https://doi.org/10.1182/blood-2025-5396

Published: 2025

Journal Articles

Facility-level disparities in outcomes of subcutaneous panniculitis-like T-cell lymphoma: A national cancer database analysis

Gabriel Giraldo Ospino, Leyla Bojanini, Erin Kaser, Victor Mendiola, Vanessa Velazquez, Daniel Rosas, Qianqian Liu, Joel Michalek, Supreet Kaur, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 8023.

https://doi.org/10.1182/blood-2025-8023

Published: 2025

Journal Articles

A national analysis on ALK+ anaplastic large cell lymphomas: Community-based care linked to similar survival outcomes compared to academic centers.

Victor Mendiola, Leyla Bojanini, Erin Kaser, Daniel Rosas, Vanessa Velazquez, Gabriel Giraldo, Qianqian Liu, Joel Michalek, Supreet Kaur, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 3642.

https://doi.org/10.1182/blood-2025-3642

Published: 2025

Journal Articles

Improved survival outcomes in angioimmunoblastic T-cell lymphoma linked to care at academic cancer centers: A national cancer database study.

Vanessa Velazquez, Leyla Bojanini, Erin Kaser, Daniel Rosas, Victor Mendiola, Gabriel Giraldo, Qianqian Liu, Joel Michalek, Supreet Kaur, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 2763.

https://doi.org/10.1182/blood-2025-2763

Published: 2025

Journal Articles

Facility-level variation in hepatosplenic T-cell lymphoma care: Comparative outcomes from academic and community cancer centers

Daniel Rosas, Leyla Bojanini, Supreet Kaur, Erin Kaser, Victor Mendiola, Vanessa Velazquez, Gabriel Giraldo, Qianqian Liu, Joel Michalek, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 3638.

https://doi.org/10.1182/blood-2025-3638

Published: 2025

Journal Articles

Impact of treatment facility type on survival outcomes in mantle cell lymphoma: A 20-year NCDB analysis

Eleftheria Atalla, Ysaith Orellana Ascencio, Carolina Velez-Mejia, Laura Reyes-Uribe, Qianqian Liu, Joel Michalek, Leyla Bojanini, Supreet Kaur, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 3572.

https://doi.org/10.1182/blood-2025-3572

Published: 2025

Journal Articles

Treatment setting matters: Academic cancer centers deliver superior survival in MALT lymphoma – an NCDB analysis of 77,000 patients

Esteban Toro Velez, Supreet Kaur, Nikki Verma, Aymen Baig, William Ciurylo, Qianqian Liu, Joel Michalek, Leyla Bojanini, Adolfo Diaz Duque

Blood (2025) 146 (Supplement 1): 2635.

https://doi.org/10.1182/blood-2025-2635

Published: 2025

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

The academic center effect: Better outcomes for patients with DLBCL

Patients with burkitt's lymphoma have a better survival probability if treated in an academic cancer program

A national lens on follicular lymphoma: Academic care linked to improved survival in 158,000 patients

Facility type and survival outcomes in extranodal NK/T-cell lymphoma, nasal type: A national cancer database analysis

Same outcomes, different odds: Socioeconomic disparities in PMBCL care across u.S. cancer centers

Academic advantage without survival benefit? a national cancer database analysis of primary effusion lymphoma

Real-world outcomes in T-cell/histiocyte-rich large B-cell lymphoma: Insights from the largest u.S. cohort to date

A tale of two settings: Survival disparities in CLL/SLL between academic and community cancer programs in the u.S. national cancer database

Unequal outcomes: The role of institutional setting in the management of primary CNS lymphoma

Academic cancer programs deliver improved long-term survival in nodular lymphocyte predominant Hodgkin lymphoma: Insights from 7,000+ United States patients

Outcomes of primary cutaneous anaplastic large cell lymphoma across u.S. cancer care settings: A national cancer database analysis.

Comparative outcomes of 14,650 patients with mycosis fungoides/Sézary syndrome from academic and community cancer programs

Clinical disparities in enteropathy-associated T-cell lymphoma: A national cancer database study of 736 patients treated at academic and community cancer centers

Curable but not equal: Survival disparities in classic Hodgkin lymphoma by treatment facility type in the United States

Facility-level disparities in outcomes of subcutaneous panniculitis-like T-cell lymphoma: A national cancer database analysis

A national analysis on ALK+ anaplastic large cell lymphomas: Community-based care linked to similar survival outcomes compared to academic centers.

Improved survival outcomes in angioimmunoblastic T-cell lymphoma linked to care at academic cancer centers: A national cancer database study.

Facility-level variation in hepatosplenic T-cell lymphoma care: Comparative outcomes from academic and community cancer centers

Impact of treatment facility type on survival outcomes in mantle cell lymphoma: A 20-year NCDB analysis

Treatment setting matters: Academic cancer centers deliver superior survival in MALT lymphoma – an NCDB analysis of 77,000 patients

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only